Starting from the basic estrogen receptor (ER) and human epidermal growth factor 2 (Her2) tumor stratification, which led to targeted treatment for breast cancer (hormone therapy and anti-Her2 therapy), efforts have moved to molecular stratification of tumors. This evidence concerns the gene ERBB2 and breast carcinoma.